RT Journal Article
SR Electronic
T1 WITHDRAWN: Proteogenomic analyses identify coagulation factor XI as a thromboinflammatory mediator of long COVID
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.17.24307553
DO 10.1101/2024.05.17.24307553
A1 Schuermans, Art
A1 Verstraete, Andreas
A1 Lammi, Vilma
A1 Nakanishi, Tomoko
A1 Ardissino, Maddalena
A1 Van den Eynde, Jef
A1 Sun, Benjamin B.
A1 Georgakis, Marios K.
A1 Van Weyenbergh, Johan
A1 Lewandowski, Adam J.
A1 Raman, Betty
A1 Ollila, Hanna M.
A1 Burgess, Stephen
A1 Natarajan, Pradeep
A1 Honigberg, Michael C.
A1 Freson, Kathleen
A1 Vanassche, Thomas
A1 Verhamme, Peter
YR 2024
UL http://medrxiv.org/content/early/2024/09/03/2024.05.17.24307553.abstract
AB The authors have withdrawn their manuscript due to analytical errors invalidating the main study findings. The authors of this work discovered the errors after submitting the initial version of the preprint. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementM.K.G. has consulted for Tourmaline Bio and serves in the Editorial Board of Neurology, both not relevant to this work. M.C.H. reports research funding from Genentech, consulting fees from Comanche Biopharma, and advisory board service for Miga Health, all unrelated to the present work. K.F. received research grants from Novo Nordisk and Swedish Orphan Biovitrum AB (Sobi). T.V. has participated in advisory boards and/or acted as a speaker on behalf of Bayer, BMS/Pfizer, Boehringer Ingelheim, Daiichi Sankyo, Leo Pharma, Sanofi Aventis. P.V. has received research funding from Bayer, BMS, Pfizer, and Leo Pharma, and honoraria from Bayer, Pfizer, BMS, Daiichi-Sankyo, Sanofi-Aventis, Leo Pharma, Anthos Therapeutics, and Astra-Zeneca.Funding StatementT.N. is supported by a research fellowship of the Japan Society for the Promotion of Science for Young Scientists (22J30004) and by a Grant-in-Aid for Scientific Research (B) (23H02917). M.K.G. is funded by the German Research Foundation in the form of an Emmy Noether grant (GZ: GE 3461/2-1, ID 512461526). B.R. is supported by a Wellcome Career Development Award fellowship (302210/Z/23/Z). H.M.O. is supported by the Academy of Finland (#1350181) and the NIH (R01AI170850). K.F. is supported by the National Institute of Health (R01Hl161365), KU Leuven (C14/23/121), research foundation Flanders (FWO; G072921N). T.V. is supported by a grant from FWO (1843423N).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used only publicly available summary statistics from genome-wide association studies performed in the UK Biobank (https://biobank.ndph.ox.ac.uk/showcase/; http://ukb-ppp.gwas.eu/) the Long COVID Host Genetics Initiative (https://my.locuszoom.org/gwas/793752/; https://www.medrxiv.org/content/10.1101/2023.06.29.23292056v1), an Icelandic cohort genotyped by deCODE (https://www.decode.com/summarydata/), and FinnGen (release 10; https://r10.finngen.fi/).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes